DW49Ttg3JA | 476013-14-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: DW49Ttg3JA
• 英文别名: 1-[2-[4-benzoyl-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl]-N,N-dimethyl-4-piperidin-1-ylpiperidine-4-carboxamide
• CAS: 476013-14-6
• 化学式: C₃₂H₄₂Cl₂N₄O₃
• 分子量: 601.6
• InChiKey: RVQZVVJLIUXDPN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  41
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  56.3
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
  申请人：——

  公开号：US20040180890A1

  公开（公告）日：2004-09-16

  The invention relates to compounds of formula: 1 as well as their salts with inorganic or organic acids, their solvates and/or their hydrates, which exhibit a very high affinity both for the human NK 2 receptors for neurokinin A and for the human NK 3 receptors for neurokinin B and are antagonists of the said receptors. The invention also relates to their method of preparation, the pharmaceutical compositions containing them and their use for the preparation of medicaments.

  该发明涉及以下结构的化合物：1，以及它们与无机或有机酸的盐、它们的溶剂合物和/或水合物，这些化合物对人类NK2受体和人类NK3受体表现出极高的亲和力，是这些受体的拮抗剂。该发明还涉及它们的制备方法、含有它们的药物组合物以及它们用于制备药物的用途。
• NOVEL PIPERIDINECARBOXAMIDE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
  申请人：EMONDS-ALT Xavier

  公开号：US20080261976A1

  公开（公告）日：2008-10-23

  The invention relates to compounds of formula (I): as well as their salts with inorganic or organic acids, their solvates and/or their hydrates, which exhibit a very high affinity both for the human NK 2 receptors for neurokinin A and for the human NK 3 receptors for neurokinin B and are antagonists of the said receptors. The invention also relates to their method of preparation, the pharmaceutical compositions containing them and their use for the preparation of medicaments.

  本发明涉及式(I)化合物，以及它们与无机或有机酸的盐、它们的溶剂化物和/或水合物，它们对于人类神经激肽A的NK2受体和神经激肽B的NK3受体表现出非常高的亲和力，并且是这些受体的拮抗剂。本发明还涉及它们的制备方法，含有它们的制药组合物以及它们用于制备药物的用途。
• PROPHYLACTIC OR THERAPEUTIC AGENT AND MEDICINAL COMPOSITION FOR IL-31-MEDIATED DISEASE
  申请人：Kyushu University, National University Corporation

  公开号：EP3881843A1

  公开（公告）日：2021-09-22

  A prophylactic or therapeutic agent for an IL-31 mediated disease, said agent comprising a neurokinin B signal blocker.

  一种 IL-31 介导疾病的预防或治疗药物，所述药物包括神经激肽 B 信号阻断剂。
• NOUVEAUX DERIVES DE PIPERIDINECARBOXAMIDE, UN PROCEDE POUR LEUR PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：Sanofi-Aventis

  公开号：EP1395582B1

  公开（公告）日：2005-05-04
• UTILISATION D'UN COMPOSE ANTAGONISTE DES RECEPTEURS NK-2 DE LA NEUROKININE A POUR LA PREPARATION DE MEDICAMENTS UTILES POUR LA PREVENTION ET LE TRAITEMENT DES DYSFONCTIONS SEXUELLES
  申请人：Sanofi-Aventis

  公开号：EP2131842A2

  公开（公告）日：2009-12-16